you need to read the preso to appreciate the significance of today's ann. To start with, the result was outstanding and it further increases the likelihood of success for other 3 phase 2 trials as they are more or less similar. Importantly, Neuren OWN the full commercial rights of all these indications and the potential size of the patient pool is 5 times bigger than Retts. FURTHER - there are hundreds of other autism related syndromes this drug can target. It's no longer a one trick pony but a full pipeline of indications!
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-8405
-
-
- There are more pages in this discussion • 2,718 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$16.15 |
Change
-0.005(0.03%) |
Mkt cap ! $2.060B |
Open | High | Low | Value | Volume |
$16.39 | $16.57 | $16.04 | $4.082M | 251.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 329 | $16.14 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.15 | 242 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 517 | 16.160 |
7 | 591 | 16.150 |
5 | 506 | 16.140 |
8 | 597 | 16.130 |
5 | 494 | 16.120 |
Price($) | Vol. | No. |
---|---|---|
16.170 | 244 | 9 |
16.180 | 461 | 8 |
16.190 | 431 | 4 |
16.200 | 636 | 4 |
16.210 | 554 | 5 |
Last trade - 11.55am 12/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |